Episode Details

OpenAI announced that an internal AI system deployed a swarm of roughly 10,000 concurrent agents over 88 hours to produce a formal Lean-verified proof addressing the Navier–Stokes Millennium Prize Problem. Meanwhile, a study published in Nature Biotechnology revealed that Insilico Medicine's AI-designed drug rentosertib significantly reduced biological age markers across six independent proteomic clocks in a Phase 2a trial.

We’ll talk about:

• A 10,000-agent AI swarm utilizing 130B output tokens to generate a 165-page proof and Lean formalization of finite-time blowup in fluid dynamics.
• Phase 2a trial data showing an AI-designed idiopathic pulmonary fibrosis drug reduced biological age markers by up to 3–4 years across six proteomic aging clocks.
• OpenAI deploying its upgraded image generation model featuring faster generation speeds, improved subject consistency, and higher visual fidelity.
• Applied AI startup Cognition securing $2 billion in new capital at a $52B valuation as its annualized revenue run rate reaches $900 million.

Keywords: OpenAI Navier Stokes, ChatGPT Images 2.5, Cognition, Meta Muse.

Links:

1. Newsletter: Sign up for our FREE daily newsletter.
2. Our Community: Get 3-level AI tutorials across industries.
3. Join AI Fire Academy: 700+ advanced AI workflows ($14,500+ Value)

Our Socials:

1. Facebook Group: Join 298K+ AI builders
2. X (Twitter): Follow us for daily AI drops
3. YouTube: Watch AI walkthroughs & tutorials